Genocea Biosciences Inc (NASDAQ:GNCA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - GNCA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - GNCA

  • Market Cap$126.510m
  • SymbolNASDAQ:GNCA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS3724274010

Company Profile

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.Genocea Biosciences Inc is a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with unmet needs. The Company's products include GEN-003 and GEN-004.

Latest GNCA news

Currently there for this company. Visit our news hub for other news .